Impact Biomedical IBO
NYSE IBO
$5.46 -0.14 (-2.50%)
As of: Oct 1, 2026 · 3:57 PM EDT

Impact Biomedical (IBO) EPS (Basic) (2022 - 2026)

Updated

Impact Biomedical's EPS (Basic) was -$0.01 in Q2 2026, compared with -$1.18 a year earlier.

Analysis

Impact Biomedical (IBO) EPS (Basic) (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Impact Biomedical's EPS (Basic) was -$0.17 through Jun 30, 2026; for FY2024, it was -$2.30.

  • In earlier years, EPS (Basic) was -$0.07 in FY2023 and -$0.10 in FY2022.
  • The Q2 2026 figure marks the highest quarterly EPS (Basic) since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.30
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.04
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -0.54
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.68
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.87
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -8.44
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 4.34
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00 -0.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.01
Mar 31, 2026 -0.02
Sep 30, 2025 -0.12
Jun 30, 2025 -1.18
Mar 31, 2025 -0.11
Dec 31, 2024 -2.52
Sep 30, 2024 0.37
Jun 30, 2024 -0.09
Mar 31, 2024 -0.10
Dec 31, 2023 -0.02
Sep 30, 2023 -0.02
Jun 30, 2023 -0.02
Mar 31, 2023 -0.01
Dec 31, 2022 -0.05
Sep 30, 2022 -0.03
Jun 30, 2022 0.00
API Access

Impact Biomedical EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=IBO&period=max&api_key=YOUR_API_KEY